Yes fair concerns, from the interview that @Sharing990 provided the link to, JK is clearly aware of these issues.
As I posted the other day:
So the NG Biotech test is available for use in Europe.
Number of cases in Europe = 1,168,284 at time of posting now 1,300,838
Number of people in Europe = 741,000,000
Seems like a good opportunity for sales in Europe alone.
Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-63
-
- There are more pages in this discussion • 1,326 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
